INS and Insulin resistance: This has led some researchers to refer to AD as “type 3 diabetes” because of the similarities between the impaired brain insulin signaling observed in AD and the insulin resistance observed in T2DM (see below) (de la Monte, 2014; Steen et al., 2005).